A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years
Recruiting · NCT05262010 · Registry updated 2026-01-16Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Phase III Clinical Trial of a 11-valent Recombinant Human Papillomavirus Vaccine (Hansenulapolymorpha) in Chinese Women Aged 9-45 Years | DNA Virus Infections, Disease Attributes, Genital Diseases, Infections, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Tumor Virus Infections, Urogenital Diseases, human papilloma virus infection, infectious disease, sexually transmitted disease, viral infectious disease, viral sexually transmitted disease | Recruiting | Phase 3 | 2026-01-16 | NCT05262010 |
8 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Hechi Yizhou District Center for Disease Control and Prevention | Hechi | China | 1 |
| Hezhou Center for Disease Control and Prevention | Hezhou | China | 1 |
| Lianyuan Center for Disease Control and Prevention | Lianyuan | China | 1 |
| Mianyang Youxian District Center for Disease Control and Prevention | Mianyang | China | 1 |
| Neijiang Shizhong District Center for Disease Control and Prevention | Neijiang | China | 1 |
| Qiyang Center for Disease Control and Prevention | Wuxi | China | 1 |
| Yongji Center for Disease Control and Prevention | Yongji | China | 1 |
| Yuanqu Center for Disease Control and Prevention | Yuncheng | China | 1 |